SMAD2 and Hepatic fibrosis: Collectively, GZFL could reduce CCl4-induced liver fibrosis in vivo by inhibiting TGF-β1/Smad2/3, CUGBP1 signaling and activating IFN-γ/STAT1/Smad7 signaling.